{"id":47928,"date":"2023-12-28T10:39:51","date_gmt":"2023-12-28T09:39:51","guid":{"rendered":"https:\/\/lvl-technologies.com\/casestudy\/modern-archiving-of-blood-donation-plasma-samples-in-blood-banks\/"},"modified":"2026-04-24T09:32:12","modified_gmt":"2026-04-24T07:32:12","slug":"saminor-3-application-note","status":"publish","type":"casestudy","link":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/","title":{"rendered":"SAMINOR 3 \u2013 UiT The Arctic University of Norway"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_row_inner][vc_column_inner][vc_custom_heading text=&#8221;Biobanking for the Population-based Study on<br \/>\nHealth and Living Conditions in Regions with<br \/>\nS\u00e1mi and Norwegian Population&#8221; font_container=&#8221;tag:h1|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;&#8221;][vc_empty_space height=&#8221;70px&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;61908&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_custom_heading text=&#8221;SAMINOR 3 \u2013 UiT The Arctic University of Norway&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]The S\u00e1mi people are the indigenous population of the North. In 2003, the collection of biological samples and information on the health and lifestyle of the S\u00e1mi community commenced in Norway in the population-based SAMINOR Study. The aims of the study are to gain insight into the preva-lence and risk factors for diseases, to prevent illness, and to improve healthcare for all.<\/p>\n<p>At the 50 regionally distributed sampling stations now conducting SAMINOR 3, which started in 2023, the samples are being collected directly into LVL SAFE\u00ae 2D Tubes. The high suitability of the tubes for both manual handling at the sampling stations and automated processing and storage of the samples was a crucial selection criterion. The pre-labeling of the tubes and racks, as well as the automation of the scanning, reading, capping, and decapping, led to significant time savings in the SAMINOR 3 study compared to the entirely manual handling and labeling during SAMINOR 1 and 2. The risk of human error in handling is significantly reduced with the new products and processes. Automated storage systems will be introduced in the next step.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=&#8221;70px&#8221;][vc_row_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_custom_heading text=&#8221;Unique Database \u2013 One of the most important sources<br \/>\nof knowledge on the health and living conditions in the<br \/>\nS\u00e1mi and Norwegian populations of rural northern Norway&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]This SAMINOR Study \u2013 The Population-based Study on Health and Living Conditions in Regions with S\u00e1mi and Norwegian Populations \u2013 places particular emphasis on the health and living conditions of the S\u00e1mi community, rendering SAMINOR a distinctive database both nationally and internationally due to its Indigenous perspective. The Centre for S\u00e1mi Health Research (CSHR) oversees the SAMINOR Study and collaborates with various research teams engaged in health research within Indigenous communities across Canada, the USA, Australia, New Zealand, Denmark\/Greenland, and Sweden. Blood samples are stored in the Core Facility for Biobank at UiT The Arctic University of Norway.<\/p>\n<p>The SAMINOR Study is a collection of surveys conducted approximately every 10 years. The surveys to date include: the SAMINOR 1 Survey (2003\u20132004), the SAMINOR 2 questionnaire Survey (2012), and the SAMINOR 2 Clinical Survey (2012\u20132014). Between 2003 and 2014, SAMINOR 1 and 2 collected data from over 30,000 individuals, whereof approximately 18,000 have donated blood samples to the biobank one or two times. Now, between 2023 and 2025, SAMINOR 3 will integrate an additional 72,000<br \/>\nparticipants from across Norway aged between 40 and 79. The SAMINOR 3 Survey, which consists of an interview survey, is already completed. The clinical ide is currently in progress. At the same time, within the framework of SAMINOR 3, the biobank is taking its first steps toward automation.<\/p>\n<p>All researchers (PhD level or equivalent) at Norwegian research institutions can apply to analyze data from SAMINOR. The use of blood samples requires approval by REC North (Regional Committee for Medical and Health Research Ethics), collective S\u00e1mi consent from the Expert Ethics Committee for S\u00e1mi Health Research, and by the SAMINOR project board, which advises the SAMINOR director.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;61909&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=&#8221;70px&#8221;][vc_row_inner][vc_column_inner][vc_single_image image=&#8221;61910&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]<\/p>\n<ul>\n<li>Participants are successively invited to a clinical examination on the bus or to the temporary research station, which gathers information on living conditions, lifestyle, health, etc., using a standardized questionnaire, medical examinations, and collection of blood, urine, and hair samples.<\/li>\n<li>Standardization of sampling conditions is achieved by deploying the same personnel, who travel to the respective stations. At any time, there are two mobile research units collecting samples at different locations, usually in two different municipalities. One research unit moved from place to place on a trailer, whereas the other is a research bus (named \u201cOdin\u201d).<\/li>\n<li>The processing of the samples includes cell isolation using centrifugation, which fractionates whole blood into its component parts, such as buffy coat and plasma.<\/li>\n<li>Eight samples per participant (3 plasma, 4 serum, 1 leukocyte) are transferred into the 1000 \u00b5l LVL SAFE\u00ae 2D Tubes, one row per SBS rack per participant, 12 participants in one rack.<\/li>\n<li>A fixed color concept is utilized for caps to ensure higher allocation security; LVL customizes delivery accordingly.<\/li>\n<li>The 8-Channel Capper\/Decapper is used for capping and decapping in all process steps. Tubes and racks are scanned.<\/li>\n<li>The samples are kept in the freezer until shipment of the sealed racks to the biobank.<\/li>\n<li>On arrival at the biobank, the tubes are re-organized by the color of their lids. The racks are scanned and read again, and the samples are placed in freezers for long-term storage at \u201370 \u00b0C.<\/li>\n<li>The introduction and evaluation of robotics and automated storage systems to increase the level of process automation is currently underway.<\/li>\n<li>Via the database, researchers may select and apply for samples from the biobank. The samples are provided in racks.<\/li>\n<li>All relevant information is assigned to the LVL SAFE\u00ae 2D code. At the research stations, each participant is linked with eight 2D codes corresponding to the eight tubes of samples associated with them. Later, this information is collected in a database and further linked to include information from questionnaires and clinical examination.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=&#8221;70px&#8221;][vc_row_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;61911&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]Product training at UiT. Showing the use of an LVL SAFE\u00ae Capper\/Decapper to cap 8 tubes with color-customized caps, and an LVL rack reader that identifies each tube and position in the 96-tube rack by reading the 2D code at the bottom of the tubes.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;61912&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]Behind, from left: Kristin S\u00f8rensen, Erik Axel Vollan, and Karina Standahl Olsen, who all work at UiT The Arctic University of Norway, and Reza Nour from Nerliens Meszansky. Front, from left: Marita Melhus, Susanna Ragnhild Siri, and Runa Borgund Barnung, who all work at UiT The Arctic University of Norway, and Claudia Emmanuel from Nerliens Meszansky.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=&#8221;70px&#8221;][vc_row_inner][vc_column_inner][vc_custom_heading text=&#8221;Customer Feedback<br \/>\nUser experience &amp; benefits&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]<\/p>\n<p data-start=\"0\" data-end=\"402\"><strong data-start=\"0\" data-end=\"173\">Flexibility of use \u2013 specifically the suitability of the products for BOTH manual handling<br \/>\nAND automated processes \u2013 was the key selection criterion<\/strong><\/p>\n<ul>\n<li data-start=\"0\" data-end=\"402\">Easy and convenient handling at the sampling stations and for the current manual storage in freezers.<\/li>\n<li data-start=\"0\" data-end=\"402\">Good compatibility with the planned expansion to include robotics and storage automation systems.<\/li>\n<\/ul>\n<p data-start=\"404\" data-end=\"1565\"><strong data-start=\"404\" data-end=\"490\">Flexibility of use \u2013 specifically the suitability of the products for BOTH manual handling<br \/>\nAND automated processes \u2013 was the key selection criterion<\/strong><\/p>\n<ul>\n<li data-start=\"404\" data-end=\"1565\">The 2D pre-labeling and the automatic scanning of tubes and racks result in high security and time savings in sample<br \/>\nhandling \u2013 benefits for accurate protocols, precise work, low error rates throughout the entire logistics chain.<\/li>\n<li data-start=\"404\" data-end=\"1565\">The option of adding a third code on the tubes allows for expansion \u2013 two options could be of interest: delivery from<br \/>\nLVL using a third human-readable code OR in-house coding with an LVL SAFE\u00ae Tube Laser Marker.<\/li>\n<li data-start=\"404\" data-end=\"1565\">Customized delivery based on the color distribution of caps in the racks yields high benefits \u2013 time savings and risk<br \/>\nreduction for mix-ups\/false fillings; yellow caps are used for serum, pink for plasma and blue for buffycoat.<\/li>\n<li data-start=\"404\" data-end=\"1565\">Easy closure of the lids \u2013 possible fit in both directions.<\/li>\n<li data-start=\"404\" data-end=\"1565\">High security of the closures \u2013 samples arrive safely and undamaged at the biobank after transport from the stations.<\/li>\n<li data-start=\"404\" data-end=\"1565\">High time savings due to the effective capping\/decapping by the LVL SAFE\u00ae 8-Channel Capper\/Decapper.<\/li>\n<\/ul>\n<p data-start=\"1567\" data-end=\"1850\"><strong data-start=\"1567\" data-end=\"1591\">High-quality support services<\/strong><\/p>\n<ul>\n<li data-start=\"1567\" data-end=\"1850\">Technical expertise of LVL staff.<\/li>\n<li data-start=\"1567\" data-end=\"1850\">Quick and uncomplicated assistance with initially encountered specific issues with the LVL SAFE\u00ae Tube and Rack Reader \u2013 close support until final resolution and satisfactory outcome.<\/li>\n<\/ul>\n<p data-start=\"1852\" data-end=\"2435\" data-is-last-node=\"\" data-is-only-node=\"\"><strong data-start=\"1852\" data-end=\"1924\">Deciding on the appropriate volume is a challenge<\/strong><\/p>\n<ul>\n<li data-start=\"1852\" data-end=\"2435\">During the evaluation phase, the decision was made for 1000 \u00b5l tubes as a compromise between available sample<br \/>\nvolumes for studies, space, and cost requirements.<\/li>\n<li data-start=\"1852\" data-end=\"2435\">There remains uncertainty about whether the volumes will be sufficient for use in the coming years or whether practical application over time will show that the use of smaller or larger tubes, or the storage of the same sample volumes in smaller tubes in higher numbers, would have been more advantageous.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=&#8221;70px&#8221;][vc_custom_heading text=&#8221;References &amp; Contact&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;&#8221;][vc_row_inner][vc_column_inner width=&#8221;1\/4&#8243;][vc_single_image image=&#8221;61913&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]<strong>Susanna Ragnhild<br \/>\nAndersdatter Siri<\/strong><br \/>\nMPH, PhD, Researcher at the<br \/>\nCentre for S\u00e1mi Health Research<br \/>\nand Co-Investigator in SAMINOR 3[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][vc_single_image image=&#8221;61914&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]<strong>Runa Borgund<br \/>\nBarnung<\/strong><br \/>\nHead Engineer at the Core Facility for<br \/>\nBiobank Faculty of Health Science, UiT[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][vc_single_image image=&#8221;61915&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]<strong>Karina Standahl<br \/>\nOlsen<\/strong><br \/>\nAssociate Professor,<br \/>\nHead of the Core Facility for Biobank,<br \/>\nFaculty of Health Science, UiT[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][vc_single_image image=&#8221;61916&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]<strong>Reza Nour<\/strong><br \/>\nLVL technologies GmbH &amp; Co. KG<br \/>\nT +47-469-84413<br \/>\n<a href=\"mailto:Reza.Nour@lvl-technologies.com\">Reza.Nour@lvl-technologies.com<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<strong>Webseite<br \/>\n<\/strong><a href=\"https:\/\/uit.no\/research\/saminor_en\" target=\"_blank\" rel=\"noopener\">https:\/\/uit.no\/research\/saminor_en<\/a><br \/>\n<a href=\"https:\/\/www.uit.no\/biobank\" target=\"_blank\" rel=\"noopener\">https:\/\/www.uit.no\/biobank<\/a><\/p>\n<p><strong>Press release<\/strong><br \/>\n<a href=\"https:\/\/uit.no\/nyheter\/artikkel\/kortnytt?p_document_id=827440\" target=\"_blank\" rel=\"noopener\">https:\/\/uit.no\/nyheter\/artikkel\/kortnytt?p_document_id=827440<\/a>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row full_width=&#8221;stretch_row&#8221; css=&#8221;.vc_custom_1776946203054{margin-bottom: -50px !important;background-color: #000000 !important;}&#8221;][vc_column][vc_empty_space height=&#8221;50px&#8221;][vc_custom_heading text=&#8221;Downloads&#8221; font_container=&#8221;tag:h2|text_align:left|color:%23FFFFFF&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;&#8221;][vc_empty_space height=&#8221;50px&#8221;]    <div class='download-item-wrapper'>\n        <div class='download-leftcolumn-wrapper'>\n            <div class='download-image-wrapper'>\n                <img decoding=\"async\" src=\"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png\" \/>            <\/div>\n            <div class='download-date-title-wrapper'>\n                <div class=\"download-title\">Applictaion Note: SAMINOR 3<\/div>            <\/div>\n        <\/div>\n        <div class='download-rightcolumn-wrapper'>\n            <a href=\"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/LVL-Download-Application-Note-Saminor.pdf\" download><\/a>        <\/div>\n    <\/div>\n    [\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"The SAMINOR 3 study focuses on the health and living conditions of the S\u00e1mi and Norwegian population and collects biological samples using LVL SAFE\u00ae 2D tubes. Automated handling and storage&hellip;","protected":false},"featured_media":48245,"menu_order":0,"template":"","format":"standard","class_list":["post-47928","casestudy","type-casestudy","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.9 (Yoast SEO v26.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>SAMINOR 3: Biobanking and Research on the Health of the S\u00e1mi and Norwegian Population<\/title>\n<meta name=\"description\" content=\"Learn more about the SAMINOR 3 study, which collects biological samples to support health research on the S\u00e1mi and Norwegian population. Discover the use of LVL SAFE\u00ae 2D tubes and automated processes for precise research outcomes.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SAMINOR 3 \u2013 UiT The Arctic University of Norway\" \/>\n<meta property=\"og:description\" content=\"Learn more about the SAMINOR 3 study, which collects biological samples to support health research on the S\u00e1mi and Norwegian population. Discover the use of LVL SAFE\u00ae 2D tubes and automated processes for precise research outcomes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/\" \/>\n<meta property=\"og:site_name\" content=\"LVL\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-24T07:32:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png\" \/>\n\t<meta property=\"og:image:width\" content=\"722\" \/>\n\t<meta property=\"og:image:height\" content=\"1025\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/\",\"url\":\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/\",\"name\":\"SAMINOR 3: Biobanking and Research on the Health of the S\u00e1mi and Norwegian Population\",\"isPartOf\":{\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png\",\"datePublished\":\"2023-12-28T09:39:51+00:00\",\"dateModified\":\"2026-04-24T07:32:12+00:00\",\"description\":\"Learn more about the SAMINOR 3 study, which collects biological samples to support health research on the S\u00e1mi and Norwegian population. Discover the use of LVL SAFE\u00ae 2D tubes and automated processes for precise research outcomes.\",\"breadcrumb\":{\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#primaryimage\",\"url\":\"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png\",\"contentUrl\":\"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png\",\"width\":722,\"height\":1025},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lvl.gundf-developer.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SAMINOR 3 \u2013 UiT The Arctic University of Norway\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/#website\",\"url\":\"https:\/\/lvl.gundf-developer.de\/en\/\",\"name\":\"LVL technologies GmbH & Co. KG\",\"description\":\"LVL&#039;d UP\",\"publisher\":{\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lvl.gundf-developer.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/#organization\",\"name\":\"LVL technologies GmbH & Co. KG\",\"url\":\"https:\/\/lvl.gundf-developer.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lvl-technologies.com\/wp-content\/uploads\/2023\/07\/cropped-Logo_LVL_white.png\",\"contentUrl\":\"https:\/\/lvl-technologies.com\/wp-content\/uploads\/2023\/07\/cropped-Logo_LVL_white.png\",\"width\":512,\"height\":512,\"caption\":\"LVL technologies GmbH & Co. KG\"},\"image\":{\"@id\":\"https:\/\/lvl.gundf-developer.de\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/lvl-technologies\/\"],\"description\":\"LVL technologies was founded by Martin von Lueder in 1986 and has continuously evolved since then. Our goal has always been to provide leading solutions in sample archiving and liquid handling worldwide. From the beginning, we have placed great importance on quality and innovation, working closely with our customers and partners to develop customized solutions that meet the specific requirements of the laboratory industry. Through constant research and development, we ensure that our products meet the latest technological standards. Our SAFE\u00ae line, known for its efficiency and environmental friendliness, offers a modern solution for every laboratory. With a strong international presence and a global network, we strive to provide excellent solutions and outstanding service to our customers worldwide.\",\"telephone\":\"+49 7951 95613-0\",\"legalName\":\"LVL technologies GmbH & Co. KG\",\"vatID\":\"DE271646441\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SAMINOR 3: Biobanking and Research on the Health of the S\u00e1mi and Norwegian Population","description":"Learn more about the SAMINOR 3 study, which collects biological samples to support health research on the S\u00e1mi and Norwegian population. Discover the use of LVL SAFE\u00ae 2D tubes and automated processes for precise research outcomes.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"SAMINOR 3 \u2013 UiT The Arctic University of Norway","og_description":"Learn more about the SAMINOR 3 study, which collects biological samples to support health research on the S\u00e1mi and Norwegian population. Discover the use of LVL SAFE\u00ae 2D tubes and automated processes for precise research outcomes.","og_url":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/","og_site_name":"LVL","article_modified_time":"2026-04-24T07:32:12+00:00","og_image":[{"width":722,"height":1025,"url":"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/","url":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/","name":"SAMINOR 3: Biobanking and Research on the Health of the S\u00e1mi and Norwegian Population","isPartOf":{"@id":"https:\/\/lvl.gundf-developer.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#primaryimage"},"image":{"@id":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#primaryimage"},"thumbnailUrl":"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png","datePublished":"2023-12-28T09:39:51+00:00","dateModified":"2026-04-24T07:32:12+00:00","description":"Learn more about the SAMINOR 3 study, which collects biological samples to support health research on the S\u00e1mi and Norwegian population. Discover the use of LVL SAFE\u00ae 2D tubes and automated processes for precise research outcomes.","breadcrumb":{"@id":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#primaryimage","url":"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png","contentUrl":"https:\/\/lvl.gundf-developer.de\/wp-content\/uploads\/2023\/12\/Screenshot-2024-07-20-114105.png","width":722,"height":1025},{"@type":"BreadcrumbList","@id":"https:\/\/lvl.gundf-developer.de\/en\/casestudy\/saminor-3-application-note\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lvl.gundf-developer.de\/en\/"},{"@type":"ListItem","position":2,"name":"SAMINOR 3 \u2013 UiT The Arctic University of Norway"}]},{"@type":"WebSite","@id":"https:\/\/lvl.gundf-developer.de\/en\/#website","url":"https:\/\/lvl.gundf-developer.de\/en\/","name":"LVL technologies GmbH & Co. KG","description":"LVL&#039;d UP","publisher":{"@id":"https:\/\/lvl.gundf-developer.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lvl.gundf-developer.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/lvl.gundf-developer.de\/en\/#organization","name":"LVL technologies GmbH & Co. KG","url":"https:\/\/lvl.gundf-developer.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lvl.gundf-developer.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/lvl-technologies.com\/wp-content\/uploads\/2023\/07\/cropped-Logo_LVL_white.png","contentUrl":"https:\/\/lvl-technologies.com\/wp-content\/uploads\/2023\/07\/cropped-Logo_LVL_white.png","width":512,"height":512,"caption":"LVL technologies GmbH & Co. KG"},"image":{"@id":"https:\/\/lvl.gundf-developer.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/lvl-technologies\/"],"description":"LVL technologies was founded by Martin von Lueder in 1986 and has continuously evolved since then. Our goal has always been to provide leading solutions in sample archiving and liquid handling worldwide. From the beginning, we have placed great importance on quality and innovation, working closely with our customers and partners to develop customized solutions that meet the specific requirements of the laboratory industry. Through constant research and development, we ensure that our products meet the latest technological standards. Our SAFE\u00ae line, known for its efficiency and environmental friendliness, offers a modern solution for every laboratory. With a strong international presence and a global network, we strive to provide excellent solutions and outstanding service to our customers worldwide.","telephone":"+49 7951 95613-0","legalName":"LVL technologies GmbH & Co. KG","vatID":"DE271646441"}]}},"_links":{"self":[{"href":"https:\/\/lvl.gundf-developer.de\/en\/wp-json\/wp\/v2\/casestudy\/47928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lvl.gundf-developer.de\/en\/wp-json\/wp\/v2\/casestudy"}],"about":[{"href":"https:\/\/lvl.gundf-developer.de\/en\/wp-json\/wp\/v2\/types\/casestudy"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lvl.gundf-developer.de\/en\/wp-json\/wp\/v2\/media\/48245"}],"wp:attachment":[{"href":"https:\/\/lvl.gundf-developer.de\/en\/wp-json\/wp\/v2\/media?parent=47928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}